Finafloxacin, a Novel Fluoroquinolone, Reduces the Clinical Signs of Infection and Pathology in a Mouse Model of Q Fever

Finafloxacin is a novel fluoroquinolone with optimal antibacterial activity in low pH environments, therefore offering a therapeutic advantage over some traditional antibiotics, in treating bacterial infections associated with acidic foci. Coxiella burnetii, the causative agent of Q fever, is a bact...

Descripción completa

Detalles Bibliográficos
Autores principales: Hartley, M. Gill, Norville, Isobel H., Richards, Mark I., Barnes, Kay B., Bewley, Kevin R., Vipond, Julia, Rayner, Emma, Vente, Andreas, Armstrong, Stuart J., Harding, Sarah V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670379/
https://www.ncbi.nlm.nih.gov/pubmed/34917048
http://dx.doi.org/10.3389/fmicb.2021.760698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670379/
https://www.ncbi.nlm.nih.gov/pubmed/34917048
http://dx.doi.org/10.3389/fmicb.2021.760698

Ejemplares similares